Shopify

Ação

ISIN: CA82509L1076

Ticker: SHOP

CA82509L1076

SHOP

Price

Discussão sobre SHOP

Postos

155

G_Lappas10

@G_Lappas10

3D·

The most “expensive” software stocks based on EV/NTM Revenue

➡️ The premium investors pay for growth is massive in some names.

#stocks
#software
#valuation

Thomas

@tvioli

3D·

📊 Market Update (Sep 2, 2025)

🇺🇸 USA

• $SPX500 — futures slightly down as markets return after the holiday with a cautious tone.

• $DJ30 — also in red, cyclicals under mild pressure.

Tech Snapshot:

•$NVDA (-3,33%) — -3.38%, profit-taking after a strong run.

• $AVGO (+8,33%) — -3.66%, semiconductor sector sentiment cooling.

• $AMZN (-1,95%) — -1.16%, e-commerce demand still resilient.

• $META (-0,3%) — -1.63%, small correction after recent rally.

•$MSFT (-3,17%) F — -0.59%, cloud growth remains supportive.

• $SHOP (+0,46%) — -0.13%, stable despite sector volatility.

🇪🇺 Europe

• $EUSTX50 futures — slightly weaker, sentiment softer.

• $GER40 futures — in mild decline as well.

European Banks:

• $UCG (-2,6%) — stable, strong buyback program.

• $ISP (-1,39%) — Q2 results supportive, solid fundamentals.

• $BPE (-1,11%) — margins improving.

• $BBVA.MC — stable loan growth.

• $CE.MI — niche focus, reliable performance.

🌏 Asia

• $JPN225 — weaker after prior rally.

• $KOSPI — slightly up, tech-driven.

• $HK50 & $CHINA50 — muted, cautious sentiment.

💳 Payments & Consumer

• $V — +0.48%, supported by strong transaction volumes.

💊 Healthcare & Pharma

• $HIMS — -3.97%, profit-taking on high-growth stock.

• $LLY — flat, pharma giant consolidating gains.

• $PHIN — -0.65%, minor drop after recent rally.

💱 Forex

• $EURUSD — euro stronger vs. USD.

• $GBPUSD — steady, awaiting UK data.

• $USDJPY — yen slightly firmer.

• $DXY — softer dollar overall.

🥇 Gold (GLD)

• $GLD — up, supported by lower yields and cautious risk sentiment.

🛢 Oil

• $WTI / $BRENT — holding firm, balanced supply and demand.

💰 Crypto

• $BTC (+0,2%) — +2.25%, bullish consolidation.

• $ETH — flat, unchanged on the day.

• $TRX — +0.59%, small uptick.

• $CRO — -5.16%, sharp correction after strong rally.

🌍 Global Insight & Crypto Deep Dive

Markets reopen with a cautious tone after the long weekend. Futures point to mild weakness, while tech leads the pullback — $NVDA and $AVGO hit hardest on profit-taking. Still, $AMZN, $META, $MSFT, and $SHOP show ongoing resilience in cloud and e-commerce.

In Europe, indices are softer, but banks remain a relative strength thanks to solid fundamentals. Asian markets trade cautiously, with China showing muted activity.

Crypto remains the hot spot: $BTC up 2% in bullish consolidation, $ETH steady, $TRX modestly higher. The outlier is $CRO, dropping over 5% after a strong rally, highlighting elevated volatility — key to watch if it stabilizes above breakout levels or continues lower.

👉 If you enjoy my daily breakdown, hit follow

Thomas

@tvioli

4D·

📊 Market Update (Sep 1, 2025)

🇺🇸 USA

• $SPX500 — futures held modest gains, continuing upward tone post-Labor Day.

• $DJ30 — futures slightly lower, industrials under gentle pressure.

Tech Snapshot:

•$NVDA (-3,33%) — unchanged over the holiday; AI chip demand remains strong.

• $AVGO (+8,33%) — down ~3.7%, strong AI and hyperscaler demand underpinning medium-term outlook.

• $AMZN (-1,95%) — down ~1.16%; e-commerce and AWS remain growth drivers.

•$META (-0,3%) — down ~1.63%; ads and cloud revenue continue holding up.

• $MSFT (-3,17%) — down ~0.58%; cloud-led momentum supports stability.

•$SHOP (+0,46%) — down ~0.13%; e-commerce resilience offsetting recent volatility.

🇪🇺 Europe

• $EUSTX50 futures — slight dip, cautious sentiment ahead of key data.

• $GER40 futures — mild pullback.

European Banks Spotlight:

• $UCG (-2,6%) — stable; investor confidence in capital returns.

• $ISP (-1,39%) — steady; Q2 fundamentals solid.

• $BPE (-1,11%) — improving profitability trends.

•$BBVA (-1,17%) — consistent execution, stable lending growth.

• $CE (-1,27%) — reliable niche performance.

🌏 Asia

• $JPN225 — mixed; semiconductors underpin performance.

• $KOSPI — modest gains; tech sector support.

• $HK50 — rangebound; cautious China sentiment.

• $CHINA50 — modest movement; cautious positioning.

💳 Payments & Consumer

• $V — up ~0.48%; strong global transaction volumes support growth.

💊 Healthcare & Pharma

•$HIMS (+0,15%) — down ~3.97%; revenue growth remains focus.

•$LLY (-2,68%) — flat (~0.00%); supported by diabetes/obesity treatments.

• $PHIN (-0,7%) — down ~0.65%; sector momentum monitored closely.

💱 Forex

• $EURUSD — euro strengthened against USD.

• $GBPUSD — stable ahead of UK macro data.

• $USDJPY — slightly firmer.

• $DXY — softened marginally.

🥇 Gold (GLD)

• $GLD (+0,58%) — edged higher, supported by softer yields and defensive positioning.

🛢 Oil

• $WTI — held firm.

• $BRENT — held firm.

💰 Crypto

• $BTC (+0,2%) — modest gains; consolidating.

• $ETH (-0,39%) — steady in upper-$4k range.

• $TRX (-0,39%) — minor pullback after recent climb.

• $CRO (+2,76%) — retraced ~5% after breakout; volatility elevated.

Global Insight & Crypto Deep Dive

September begins cautiously: U.S. futures show tentative strength, Europe and Asia rangebound ahead of macro data (ISM, PMI, NFP). Broadcom (~–3.7%) retracement highlights sensitivity to global demand, while Amazon and Meta reflect rotation in tech. Microsoft and Shopify show relative stability.

In crypto, $BTC and $ETH remain steady, providing a base, while $CRO retraces after breakout—watch support levels closely; recovery could reignite momentum, failure could lead to deeper correction.

✨ If you enjoy my daily analysis, make sure to follow me.

1 Comentar

John

@Doe

3Semana·

Cathie Woods ARK ETFs make large purchases at The Trade Desk and sell block position

Cathie Wood's ARK ETFs once again saw significant transactions on Tuesday, August 12, 2025, with a focus on technology and biotech stocks. The largest transaction of the day was the purchase of 738,367 shares of The Trade Desk Inc ( $TTD (-0,52%) ) with a total value of $39,266,357. This move underscores ARK's continued confidence in the digital advertising platform, where the fund had already significantly increased its positions in recent days.

Another notable transaction involved Block Inc ( $SQ (-1,55%) ), formerly known as Square. Here ARK sold 215,543 shares, representing a sizable value of $15,741,105. This sale represents one of the larger divestitures of the day and could indicate a strategic realignment of ARK's position towards the financial services and digital payments company.

ARK also made a significant purchase of 643,406 shares of Pinterest Inc ( $PINS ) worth $21,998,051. The social media company has repeatedly been in ARK's focus in the past, as evidenced by the continuous purchases over the past week. This trend points to a bullish assessment of Pinterest's growth prospects on the part of ARK.

In the biotech sector, ARK's ARK ETF purchased 128,896 shares of CRISPR Therapeutics AG ( $CRSP (+2,86%) ) for a total value of $714,567, continuing its investment in the gene-editing company. On the flip side, various ARK ETFs divested shares of DraftKings Inc ( $DKNG (-2,53%) ), Guardant Health Inc ( $GH (-2,6%) ), Robinhood Markets Inc ($HOOD (-2,19%) ), Palantir Technologies Inc ($PLTR ), Roblox Corp ( $RBLX ) and Shopify Inc ($SHOP (+0,46%) ). The largest sell-off was DraftKings, with 221,203 shares worth $9,452,004 sold.

Other notable buys included Exact Sciences Corp ( $EXAS (+5,31%) ) and Personalis Inc ( $PSNL (+1,83%) ). ARK bought 93,753 and 134,035 shares worth $3,835,435 and $603,157 respectively. The continued purchases in these stocks could indicate a focused strategy targeting innovative healthcare companies.

Smaller transactions were also part of the day's activity. ARK bought shares in Compass Pathways PLC ( $CMPS (-0,9%) ) and 10X Genomics Inc ( $TXG (+2,32%) ). Despite the smaller dollar amounts, these purchases could be part of a long-term strategy that focuses on up-and-coming companies in the respective sectors.

Some of dear Cathie's transactions don't need to be understood but well, the young lady's returns speak for themselves.

$ARKK (+0%) and $ARKF (-0,76%) over 70% return since 365 days, I can only shine with +27% with my portfolio.

I will remain invested in $TTD (-0,52%) My current portfolio has a lot of risk, as I have generated some cash.

At the moment I'm considering whether I should possibly $HMWO (-0,7%) and $EQQQ (-0,59%) or just the $VUSA (-0,88%) into the portfolio.

Temporarily sold $AMD (-7,23%) +35%, $HIMS (+0,15%) +15%, $DOCN (+1,6%) +9%.

I would re-enter Hims and AMD at certain prices and possibly add other companies to the portfolio if they fit my selection.

My positions:

On the watchlist

5 Comentários

3Semana

Well done, Ms. Holz.

•

Ordovicium

@Ordovicium

4Semana·

Buy?

$SHOP (+0,46%) After the big rise, I'm thinking of buying. I guess tomorrow it will go the other way. Should I place a trailing stop-buy order? What limit or range would you choose?

4 Comentários

Frank@BlueVelvet

4Semana

With a P/E ratio of around 100, a P/B ratio of 11 and a P/B ratio of 17, it is simply brutally overvalued (I got the figures from Eulerpool). I fear that it will be punished if it fails to meet the high expectations in one quarter. On a positive note, however, the leverage ratio of 0.1 indicates excellent short-term liquidity - i.e. the interest can easily be serviced from the cash flow. Based on the other factors, however, it is too hot for me at the moment.

•

Mostrar resposta

Soprano

@Soprano

4Semana·

So now also

I have 50 shares of $NOVO B (-2,31%) at a price of €66. I still believe that it is not wrong to be positioned with Novo and $UNH (+1,39%) (10 shares at €353), but perhaps one should not overdo it. The positions are large enough to have a noticeable effect on a full recovery, but I don't need to overload myself to create an even bigger buy-in.

Basically, there is much to suggest that the market is simply acting excessively panicky and headless and that the healthcare sector itself is not in demand (see post before last). Especially when Trump is throwing out some TACOs saying that he wants to regulate pharmaceutical prices - and although pharma is taking a dive, health insurers are still not benefiting from this. A lot of things on the market don't fit together at the moment.

Sometimes I'm also right. Sometimes. I have $SHOP (+0,46%) at €30 and $NVDA (-3,33%) for €12 when nobody wanted the shares, but the trick is of course that you always have too many shares in stocks that fall and too few in stocks that rise. You can sometimes make the perfect start with a single tranche, but you will rarely take €100,000 in the morning after a good night's sleep and find the golden turnaround with a single purchase ... so just in case anyone gets the idea that you can simply get in later when the shares are rising again: you won't do that anyway.